Autoimmune Hemolytic Anemia

Common Name(s)

Autoimmune Hemolytic Anemia

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Autoimmune Hemolytic Anemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Autoimmune Hemolytic Anemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Autoimmune Hemolytic Anemia" returned 126 free, full-text research articles on human participants. First 3 results:

Severe refractory autoimmune hemolytic anemia with five-year complete hematologic response to third course of treatment with rituximab: a case report.
 

Author(s): Kathleen Abadie, Kristen M Hege

Journal:

 

Rituximab is an emerging treatment for autoimmune hemolytic anemia. We report the case of a patient with a five-year complete hematologic response to a third course of treatment with rituximab. Cases of response to rituximab re-treatments have been reported, but none to our knowledge ...

Last Updated: 2 Jul 2014

Go To URL
Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with Peg interferon alfa-2a and ribavirin.
 

Author(s): Rym Ennaifer, Myriam Cheikh, Hayfa Romdhane, Rania Hefaiedh, Houda Ben Nejma, Najet Bel Hadj

Journal: Tunis Med. 2014 Jan;92(1):42-3.

 

Last Updated: 2 Jun 2014

Go To URL
Anti B cell targeted therapy for autoimmune hemolytic anemia in an infant.
 

Author(s): Darshak Makadia, Sirisha Rani Siddaiahgari, M S Latha

Journal: Indian J Pharmacol. ;45(5):526-7.

 

Autoimmune hemolytic anemia (AIHA) is an immune mediated destruction of erythrocytes, which has a good prognosis in children. It is known to have chronic, remitting or relapsing course, especially in infants and adolescents. Treatment of refractory or relapsing AIHA is a challenge ...

Last Updated: 16 Oct 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Autoimmune Hemolytic Anemia" returned 8 free, full-text review articles on human participants. First 3 results:

Immunotherapy treatments of warm autoimmune hemolytic anemia.
 

Author(s): Bainan Liu, Wangang Gu

Journal: Clin. Dev. Immunol.. 2013 ;2013():561852.

 

Warm autoimmune hemolytic anemia (WAIHA) is one of four clinical types of autoimmune hemolytic anemia (AIHA), with the characteristics of autoantibodies maximally active at body temperature. It produces a variable anemia-sometimes mild and sometimes severe. With respect to the absence ...

Last Updated: 9 Oct 2013

Go To URL
[Rituximab for the treatment of refractory autoimmune hemolytic anemia and pseudothrombocytopenia in infant: a case report and literature review].
 

Author(s): Wen-bin An, Ye Guo, Shu-chun Wang

Journal: Zhonghua Xue Ye Xue Za Zhi. 2012 Nov;33(11):957-9.

 

Last Updated: 31 Jan 2013

Go To URL
Diffuse nodular lymphoid hyperplasia of intestine in selective IgG 2 subclass deficiency, autoimmune thyroiditis, and autoimmune hemolytic anemia: case report and literature review.
 

Author(s): Vikas Garg, Seth Lipka, Kaleem Rizvon, Jaspreet Singh, Sadat Rashid, Paul Mustacchia

Journal: J Gastrointestin Liver Dis. 2012 Dec;21(4):431-4.

 

Diffuse Nodular Lymphoid Hyperplasia (DNLH) of the intestine is a rare lymphoproliferative disorder of uncertain etiology, which is characterized by the presence of multiple nodular lesions. It can present as an asymptomatic disease or manifest with gastrointestinal symptoms like ...

Last Updated: 20 Dec 2012

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Immunopathology of Autoimmune Hemolytic Anemia
 

Status: Recruiting

Condition Summary: Autoimmune Hemolytic Anemia

 

Last Updated: 5 Jun 2014

Go to URL
Sirolimus for Autoimmune Disease of Blood Cells
 

Status: Recruiting

Condition Summary: Autoimmune Pancytopenia; Autoimmune Lymphoproliferative Syndrome (ALPS); Evans Syndrome; Idiopathic Thrombocytopenic Purpura; Anemia, Hemolytic, Autoimmune; Autoimmune Neutropenia; Lupus Erythematosus, Systemic; Inflammatory Bowel Disease; Rheumatoid Arthritis

 

Last Updated: 17 Oct 2014

Go to URL